Olympiad Research’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,147
Closed -$237K 119
2025
Q4
$237K Sell
1,147
-90
-7% -$17.8K 0.63% 48
2025
Q3
$229K Sell
1,237
-947
-43% -$162K 0.32% 136
2025
Q2
$334K Buy
+2,184
New +$336K 0.54% 37
2022
Q3
$726K Hold
4,442
0.39% 75
2022
Q2
$788K Buy
4,442
+525
+13% +$93.5K 0.35% 87
2022
Q1
$694K Hold
3,917
0.21% 118
2021
Q4
$670K Buy
3,917
+1,306
+50% +$214K 0.24% 109
2021
Q3
$422K Hold
2,611
0.13% 155
2021
Q2
$430K Hold
2,611
0.15% 138
2021
Q1
$429K Hold
2,611
0.18% 120
2020
Q4
$411K Buy
+2,611
New +$385K 0.24% 73

Other funds holding JNJ

Olympiad Research's JNJ Position: Q1 2026 in Review

Olympiad Research sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 1,147 shares — an estimated $237K sold.

Olympiad Research first reported a position in JNJ in Q4 2020 and held it in 11 quarters. The position peaked at $788K in Q2 2022. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Olympiad Research reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Olympiad Research sold 1,147 Johnson & Johnson shares in Q1 2026, an estimated $237K.
  • Olympiad Research first reported a position in Johnson & Johnson in Q4 2020 and held it in 11 quarters.
  • Olympiad Research's Johnson & Johnson position peaked at $788K in Q2 2022.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Olympiad Research's 13F filing for Q1 2026, filed 13 May 2026.